Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
See something you like but unsure how it works with your body
The role of tirzepatide, dual GIP and GLP-1 Receptor agonist, in the management of type 2 diabetes: the SURPASS clinical trials
Orders placed before 2:00 PM EST ship same day
Both tirzepatide (Mounjaro) and semaglutide (Wegovy) are weekly injections, and after each dose the medication level in your bloodstream rises over the following 24 to 48 hours before gradually plateauing
US$ 29.38
US$ 25.58
US$ 20.31
US$ 22.05
US$ 24.20
US$ 21.98
US$ 21.81
